KPIs & Operating Metrics(New)
Growth Metrics

Chemed (CHE) Cash & Current Investments (2016 - 2026)

Chemed filings provide 18 years of Cash & Current Investments readings, the most recent being $16.9 million for Q1 2026.

  • For the quarter ending Q1 2026, Cash & Current Investments fell 90.31% year-over-year to $16.9 million, compared with a TTM value of $16.9 million through Mar 2026, down 90.31%, and an annual FY2025 reading of $74.5 million, down 58.22% over the prior year.
  • Cash & Current Investments hit $16.9 million in Q1 2026 for Chemed, down from $74.5 million in the prior quarter.
  • The five-year high for Cash & Current Investments was $313.3 million in Q1 2024, with the low at $7.8 million in Q3 2022.
  • Median Cash & Current Investments over the past 5 years was $159.9 million (2023), compared with a mean of $139.0 million.
  • The sharpest move saw Cash & Current Investments plummeted 91.36% in 2022, then soared 2125.29% in 2023.
  • Year by year, Cash & Current Investments stood at $74.1 million in 2022, then skyrocketed by 256.09% to $264.0 million in 2023, then crashed by 32.43% to $178.4 million in 2024, then tumbled by 58.22% to $74.5 million in 2025, then tumbled by 77.38% to $16.9 million in 2026.
  • According to Business Quant data, Cash & Current Investments over the past three periods came in at $16.9 million, $74.5 million, and $129.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.